Huvepharma acquires CORID trademark

CORID had been distributed by Merial.

Huvepharma announced May 2 that it acquired the CORID trademark (amprolium) from Merial Inc. (now a part of Boehringer Ingelheim), effective April 27.

Register to view the full article

You need to register to view the content,

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.